Tuesday, May 11, 2021
Home Global Issues FDA to authorize Pfizer's Covid-19 vaccine for 12-to-15-year-olds by early next week,...

FDA to authorize Pfizer’s Covid-19 vaccine for 12-to-15-year-olds by early next week, official says

Pfizer has utilized for emergency use authorization for its coronavirus vaccine for teenagers and kids ages 12 to 15. The FDA may have to amend the emergency use authorization for the vaccine, however the course of must be simple, mentioned the official, who was not licensed to communicate in regards to the course of publicly and requested anonymity.

The FDA is presently reviewing information submitted by Pfizer to help the prolonged use. Pfizer mentioned on the finish of March {that a} scientific trial involving 2,260 12-to-15-year-olds confirmed its efficacy is 100% and it’s effectively tolerated. The vaccine is presently licensed within the US for emergency use in folks 16 and older.

Pfizer/BioNTech says its Covid-19 vaccine is 100% effective and well tolerated in adolescents

Before issuing the EUAs for the three licensed coronavirus vaccines, the FDA held conferences of its impartial Vaccines and Related Biological Products Advisory Committee to evaluation the info and vote on whether or not to advocate EUA. That is not going to occur in extending EUA to 12-to-15-year-olds, the FDA has instructed CNN.

“While the FDA cannot predict how long its evaluation of the data and information will take, the agency will review the request as expeditiously as possible using its thorough and science-based approach,” the FDA mentioned in an e mail to CNN final week.

“Based on an initial evaluation of the information submitted, at this time, the agency does not plan to hold a meeting of the Vaccines and Related Biological Products Advisory Committee (VRBPAC) on this request to amend the EUA for the Pfizer-BioNTech COVID-19 Vaccine, which was discussed and recommended for authorization at a VRBPAC meeting in December 2020. As with all FDA-authorized COVID-19 vaccines, we are committed to transparency with this EUA review process.”

This 12-year-old is happy to be testing a Covid-19 vaccine

A US Centers for Disease Control and Prevention advisory committee referred to as the Advisory Committee on Immunization Practices will schedule a gathering for after any FDA resolution to prolong the EUA to new age teams. ACIP will advise CDC on whether or not to advocate use of the vaccine in 12-to-15-year-olds, after which CDC Director Dr. Rochelle Walensky will determine whether or not the company will advocate its use within the new age group.

Pfizer and Moderna each are testing their vaccines in youngsters as younger as 6 months and count on to ask the FDA for EUAs masking infants and kids later this 12 months.

Extending EUA to youthful youngsters shall be a unique matter, the official mentioned.

“In the older group of children if there is nothing exceptional, if everything looks very similar to adults, the feeling is that it is not necessary to take this to an advisory committee meeting,” the official mentioned. “For the younger children, we almost certainly will consider more strongly going to an advisory committee meeting.”

Maryland-based Novavax, in the meantime, introduced Monday it has expanded its Phase 3 trial for its Covid-19 vaccine to embody up to 3,000 youngsters ages 12 to 17 throughout the United States. They will obtain the vaccine candidate or placebo in two doses 21 days aside.

Novavax’s Covid-19 vaccine isn’t but licensed for emergency use within the United States.

Leave a Reply

Tuesday, May 11, 2021
All countries
Total confirmed cases
Updated on May 11, 2021 12:32 am

Most Popular

Most Trending

Recent Comments

Chat on WhatsApp
How can we help you?
%d bloggers like this: